Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer-a multicentre, open, controlled, prospectively randomised trial

Author: von Minckwitz G.   Loibl S.   Brunnert K.   Kreienberg R.   Melchert F.   Mosch R.   Neises M.   Schermann J.   Seufert R.   Stiglmayer R.   Stosiek U.   Kaufmann   for the South West German Gynecologic Oncology Group SWGGOG  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.38, Iss.17, 2002-11, pp. : 2265-2271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content